|
⚲
|
| Keyboard |
| Thomas Koestler | |
|---|---|
| Firm | |
| Address | 300 George Street, Suite 301 New Haven, CT 06511 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Melinta Therapeutics Inc /New/ | 021-303743 | Director | 137.8 M of 137.8 M |
||
| Melinta Therapeutics Inc /New/ | 021-299206 | Director | 132.9 M of 132.9 M |
||
| Immusant Inc | 021-298664 | Director | 19.9 M of 39.9 M |
||
| Immusant Inc | 021-231198 | Director | 12.8 M of 12.8 M |
||
| Arisaph Pharmaceuticals Inc | 021-205640 | Director | 10.0 M of 20.0 M |
||
| Pearl Therapeutics Inc | 021-186913 | Director | 13.3 M of 14.3 M |
||
| Pearl Therapeutics Inc | 021-186914 | Director | 23.3 M of 66.1 M |
||